1

Ignis Therapeutics

CNS diseases

HBM contact: Dr Emil Bujak

Company status: private

Ignis Therapeutics is developing and commercializing in China a pipeline of CNS-focused products including FDA-approved cenobamate and solriamfetol.

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171